Franklin Resources’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.53M | Sell |
|
|||||
|
2024
Q3 | $24.6M | Sell |
|
|||||
|
2024
Q2 | $16.1M | Sell |
|
|||||
|
2024
Q1 | $30.9M | Buy |
|
|||||
|
2023
Q4 | $41.7M | Buy |
|
|||||
|
2023
Q3 | $46.3M | Buy |
|
|||||
|
2023
Q2 | $57.3M | Sell |
|
|||||
|
2023
Q1 | $73.3M | Sell |
|
|||||
|
2022
Q4 | $44M | Sell |
|
|||||
|
2022
Q3 | $64.4M | Buy |
|
|||||
|
2022
Q2 | $32.7M | Buy |
|
|||||
|
2022
Q1 | $43.2M | Buy |
|
|||||
|
2021
Q4 | $29.7M | Sell |
|
|||||
|
2021
Q3 | $50.8M | Sell |
|
|||||
|
2021
Q2 | $54.1M | Buy |
|
|||||
|
2021
Q1 | $49.1M | Buy |
|
|||||
|
2020
Q4 | $49.8M | Sell |
|
|||||
|
2020
Q3 | $64.8M | Sell |
|
|||||
|
2020
Q2 | $83.3M | Sell |
|
|||||
|
2020
Q1 | $54.6M | Buy |
|
|||||
|
2019
Q4 | $58.2M | Buy |
|
|||||
|
2019
Q3 | $46.4M | Buy |
|
|||||
|
2019
Q2 | $45.6M | Buy |
|
|||||
|
2019
Q1 | $54M | Buy |
|
|||||
|
2018
Q4 | $59.9M | Buy |
|
|||||
|
2018
Q3 | $63.4M | Sell |
|
|||||
|
2018
Q2 | $72.9M | Sell |
|
|||||
|
2018
Q1 | $97.7M | Sell |
|
|||||
|
2017
Q4 | $121M | Buy |
|
|||||
|
2017
Q3 | $90.6M | Sell |
|
|||||
|
2017
Q2 | $89.1M | Buy |
|
|||||
|
2017
Q1 | $62.1M | Sell |
|
|||||
|
2016
Q4 | $67.9M | Buy |
|
|||||
|
2016
Q3 | $50.4M | Sell |
|
|||||
|
2016
Q2 | $43.1M | Sell |
|
|||||
|
2016
Q1 | $58.1M | Buy |
|
|||||
|
2015
Q4 | $109M | Sell |
|
|||||
|
2015
Q3 | $96.5M | Buy |
|
|||||
|
2015
Q2 | $98.1M | Sell |
|
|||||
|
2015
Q1 | $70.4M | Buy |
|
|||||
|
2014
Q4 | $46.7M | Buy |
|
|||||
|
2014
Q3 | $26.8M | Buy |
|
|||||
|
2014
Q2 | $11.8M | Buy |
|